Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMT vs GSK✓SelectedUSD · GSKAMT vs GSK performance historyLatest closeAs of-3.96%11/17
Stock and ETF performance explorer

AMT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-16.3%
GSK return
+43.9%
Excess return
-60.3%
Maximum drawdown
-43.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-2.3%-1.6%-3.3%
7D-3.8%-3.0%-0.8%-2.9%
30D-1.1%+0.4%-1.5%-1.3%
3M+7.5%-1.2%+8.7%+7.7%
6M+9.6%+0.9%+8.6%+9.0%
YTD+7.5%+4.0%+3.5%+5.4%
1Y+5.6%+7.3%-1.7%+2.5%
3Y+3.0%+57.1%-54.1%-12.9%
5Y-16.3%+43.0%-59.3%-30.2%
All-16.3%+43.9%-60.3%-30.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling